abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by abrdn Life Sciences Investors insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $10.5K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$10.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for abrdn Life Sciences Investors, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mahai Chris LaVictoire | Director | 527 | Jul 20, 2026 | 1 |
| Pittard Christian | Director | 7,923 | Dec 18, 2025 | 1 |
| Saba Capital Management, L.P. | 10% Owner | 2,837,633Indirect | Sep 23, 2025 | 0 |
| Weinstein Boaz | 10% Owner | 2,968,623Indirect | Sep 4, 2025 | 0 |
| Maher Bill | Director | 1,715Indirect | Aug 27, 2024 | 0 |
| DiMartino Rose | Director | 1,000 | Jul 18, 2024 | 0 |
| Goetz Kathleen | Director | 1,085 | Apr 12, 2024 | 0 |
| Reit Todd | Director | 1,000 | Jan 4, 2024 | 0 |
| Omstead Daniel R | President | 197,518 | Sep 25, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2024 (view filing)8:00 PM ET | Apr 22-23 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +50.2K | $13.14 | +$659.9K | +1.8%2.79M after | 2 lots |
| Apr 22, 2024 (view filing)3:08 PM ET | Apr 18-19 | 4 days | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +124.2K | $12.81 | +$1.59M | +4.8%2.74M after | 2 lots |
| Apr 12, 2024 (view filing) | Apr 9 | 3 daysLate | Goetz KathleenDirector | PPurchase | +400 | $13.32 | +$5.33K | +58.4%1.09K after | |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Reit ToddDirector | PPurchase | +1.00K | $13.80 | +$13.8K | New position1.00K after | |
| Jan 2, 2024 (view filing) | Dec 28, 2023 | 5 days | Maher BillDirector | PPurchase | +1.00K | $13.57 | +$13.6K | New position1.00K after | |
| Sep 25, 2023 (view filing) | Sep 25 | Same day | Omstead Daniel RPresident | PPurchaseShares of Beneficial Interest | +10.1K | $12.39 | +$125.1K | +5.4%197.5K after | |
| Sep 20, 2023 (view filing) | Sep 20 | Same day | Omstead Daniel RPresident | PPurchaseShares of Beneficial Interest | +12.0K | $12.68 | +$152.2K | +6.8%187.4K after | |
| Mar 24, 2022 (view filing) | Mar 23 | 1 day | Goetz KathleenDirector | PPurchaseShares of Beneficial Interest | +92.31 | $16.27 | +$1.50K | +15.6%685.31 after | |
| Jan 27, 2022 (view filing) | Jan 26 | 1 day | Goetz KathleenDirector | PPurchaseShares of Beneficial Interest | +593 | $17.54 | +$10.4K | New position593 after | |
| Aug 12, 2021 (view filing) | Aug 11 | 1 day | Omstead Daniel RPresident | PPurchaseShares of Beneficial Interest | +6.40K | $21.63 | +$138.5K | +4.6%146.5K after |